Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-Analysis

To identify the advantageous therapy as the first-line treatment for patients with triple-negative breast cancer (TNBC). Randomized controlled trials were searched for on Medline, Embase, ClinicalTrials.gov, and the Cochrane Library between January 2001 and December 2021. The primary endpoint was pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yiqun, Wang, Jiayu, Wu, Yun, Xu, Hangcheng, Wang, Yan, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777258/
https://www.ncbi.nlm.nih.gov/pubmed/36547132
http://dx.doi.org/10.3390/curroncol29120718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777258/
https://www.ncbi.nlm.nih.gov/pubmed/36547132
http://dx.doi.org/10.3390/curroncol29120718

Ejemplares similares